European Journal of Endocrinology · 2003 · 27 citations · 16 references
Life SciencesEndocrinologySurgeryEndocrine OncologyHormone BiochemistrySteroid BiochemistryAdrenal EndocrinologyAdrenal HormonesAdrenal Steroid HormonesAdrenal SteroidogenesisAdrenal TumorsEndocrine TumorsAdrenal AdenomasAdrenal Cortex FunctionAdrenal Steroid MetabolismAndrogen-secreting Adrenal TumorsAromatase ActivityAromatase ExpressionEstrogen-secreting Adrenal TumorsQuantitative Pcr Detection
A 30-year-old male was referred for the rapid development of gynecomastia, and dramatic hyperestrogenemia was assessed: plasma estrone, estradiol but also cortisol were not suppressed by high-dose dexamethasone, while gonadotropin pulsatility was completely abolished. A 60-mm right adrenal tumor was evidenced on computed tomography-scan, and the patient underwent adrenalectomy. The tumor was found to express a moderate increase in aromatase activity compared with adjacent non-neoplastic adrenal tissue. Quantitative RT-PCR also showed a weak and non-significant increase in total aromatase mRNA in the tumor compared with normal adrenal tissue. Aromatase transcripts were mainly promoter PII-derived, but different patterns of aromatase minor transcripts were found: promoter I.3- and I.6-derived transcripts were identified in the tumor, while only promoter I.4-derived transcripts were found in normal adrenal. This case report demonstrates that a sharp aromatase overexpression is not a prerequisite for clinical and biochemical hyperestrogenism, and further characterizes the aromatase promoter utilization in this feminizing adrenocortical tumor and in the normal adrenal cortex.
16
Nobuhiro Harada, Toshiaki Utsumi, Y. Takagi · Proceedings of the National Academy of Sciences · 1993 · 361 citations
FEMINIZING ADRENOCORTICAL TUMORS IN THE MALE
J. Lester Gabrilove, Dinesh C Sharma, Herbert H. Wotiz et al. · Medicine · 1965 · 180 citations
Medicine, Endocrinology, Oncology +12